A powerful new tool in the fight against HIV has arrived, but whether South Africa can afford it remains uncertain. The FDA’s recent approval of Lenacapavir, a biannual injectable HIV prevention drug, has sparked hope and debate. - THE MORNING BRIEF - Omny.fm

THE MORNING BRIEF

A powerful new tool in the fight against HIV has arrived, but whether South Africa can afford it remains uncertain. The FDA’s recent approval of Lenacapavir, a biannual injectable HIV prevention drug, has sparked hope and debate.

View description Share

Guest: Sibongile Tshabalala: Chairperson, Treatment Action Campaign & HIV Activist 

In 1 playlist(s)

THE MORNING BRIEF
18,252 clip(s)

THE MORNING BRIEF

THE MORNING BRIEF

Social links

Website

Recent clips

EFF Gauteng Condemns in the Strongest Terms the Collapse of the City of Ekurhuleni Council as a Direct Result of the Reckless and Unilateral Actions of ANC Executive Mayor,  Nkosindiphile Xhakaza
08:21
Latest business news with Ntaoleng Lechela - Business Reporter
04:25
Johannesburg Regional Chairperson, Loyiso Masuku has now been elected as the City of Joburg's first Deputy Mayor
09:18

Browse 18,293 clip(s)